AdvanSource Biomaterials Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and AdvanSource Biomaterials are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days AdvanSource Biomaterials has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, AdvanSource Biomaterials is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
AdvanSource |
AdvanSource Biomaterials Relative Risk vs. Return Landscape
If you would invest (100.00) in AdvanSource Biomaterials on October 30, 2025 and sell it today you would earn a total of 100.00 from holding AdvanSource Biomaterials or generate -100.0% return on investment over 90 days. AdvanSource Biomaterials is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than AdvanSource, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AdvanSource Biomaterials Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AdvanSource Biomaterials for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AdvanSource Biomaterials can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| AdvanSource Biomaterials is not yet fully synchronised with the market data | |
| AdvanSource Biomaterials has some characteristics of a very speculative penny stock | |
| AdvanSource Biomaterials has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (287 K) with profit before overhead, payroll, taxes, and interest of 2.47 M. | |
| AdvanSource Biomaterials currently holds about 186 K in cash with (282 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 90.0% of the company shares are held by company insiders |
AdvanSource Biomaterials Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AdvanSource Pink Sheet often depends not only on the future outlook of the current and potential AdvanSource Biomaterials' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AdvanSource Biomaterials' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 944.7 K | |
| Cash And Short Term Investments | 246 K |
AdvanSource Biomaterials Fundamentals Growth
AdvanSource Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of AdvanSource Biomaterials, and AdvanSource Biomaterials fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AdvanSource Pink Sheet performance.
| Return On Equity | -51.46 | |||
| Return On Asset | -495.48 | |||
| Current Valuation | 4.83 M | |||
| Shares Outstanding | 5.68 M | |||
| Price To Earning | 8.24 X | |||
| Price To Book | 37.43 X | |||
| Price To Sales | 0.35 X | |||
| EBITDA | (287 K) | |||
| Cash And Equivalents | 186 K | |||
| Cash Per Share | 0.03 X | |||
| Debt To Equity | 0.06 % | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (282 K) | |||
| Earnings Per Share | (0.52) X | |||
| Total Asset | 250 K | |||
| Retained Earnings | (37.82 M) | |||
| Current Asset | 579 K | |||
| Current Liabilities | 591 K | |||
Things to note about AdvanSource Biomaterials performance evaluation
Checking the ongoing alerts about AdvanSource Biomaterials for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for AdvanSource Biomaterials help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AdvanSource Biomaterials is not yet fully synchronised with the market data | |
| AdvanSource Biomaterials has some characteristics of a very speculative penny stock | |
| AdvanSource Biomaterials has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (287 K) with profit before overhead, payroll, taxes, and interest of 2.47 M. | |
| AdvanSource Biomaterials currently holds about 186 K in cash with (282 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Roughly 90.0% of the company shares are held by company insiders |
- Analyzing AdvanSource Biomaterials' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AdvanSource Biomaterials' stock is overvalued or undervalued compared to its peers.
- Examining AdvanSource Biomaterials' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AdvanSource Biomaterials' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AdvanSource Biomaterials' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AdvanSource Biomaterials' pink sheet. These opinions can provide insight into AdvanSource Biomaterials' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in AdvanSource Pink Sheet
If you are still planning to invest in AdvanSource Biomaterials check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AdvanSource Biomaterials' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |